Novo Nordisk vs Pfizer: Revenue Comparison
Novo Nordisk (NVO) and Pfizer (PFE) are peers in GLP-1. Novo Nordisk reported revenue of $96.8B as of Q1 2026, compared with $14.5B for Pfizer. Novo Nordisk leads on revenue.
Novo Nordisk's gross margin is 86.0% versus 67.3% for Pfizer. Novo Nordisk's net margin is 50.1% versus 18.6% for Pfizer.
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Novo Nordisk 96.823, Pfizer 14.451.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Novo Nordisk, Pfizer.| Metric | Novo Nordisk | Pfizer |
|---|---|---|
| Market Cap | - | - |
| Revenue | $96.82B | $14.45B |
| Cost of Revenue | $13.60B | $4.73B |
| Gross Profit | $83.22B | $9.72B |
| Operating Income | $59.62B | $4.03B |
| Net Income | $48.56B | $2.69B |
| R&D Expense | $10.28B | $2.63B |
| Earnings Per Share | $10.91 | $0.47 |
| Gross Margin | 86.0% | 67.3% |
| Operating Margin | 61.6% | 27.9% |
| Net Profit Margin | 50.1% | 18.6% |
| Free Cash Flow | $12.04B | $2.18B |
| Cumulative Free Cash Flow | $654.97B | $356.40B |
| Operating Cash Flow | $24.08B | $2.62B |
| Cash & Equivalents | $21.13B | $1.70B |